Evidence map›Paper›PMID 41862677›Full record

ArticleInflammation2026

IRGM1-IRF7 Axis Controls Macrophage Chemotaxis to Orchestrate Skeletal Muscle Regeneration.

Jiaqi Wang, Xuemin Ge, Zhaonan Zhang, Zhenhai Wang, Zhixin Qiao, Xinyi Wang, Yuting Weng, Xiuhua Yao, Yihe Zhang, Xiaoyu Zhang and 6 more

Abstract read
In one paragraph

Article in Inflammation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Jiaqi WangDepartment of Neurology, The Second Affiliated Hospital of Harbin Medical University, Harbin Medical University, Harbin, Heilongjiang, 150081, China.
Xuemin GeDepartment of Neurobiology, School of Basic Medical Sciences, Harbin Medical University, Harbin, Heilongjiang, 150081, China.
Zhaonan ZhangDepartment of Neurobiology, School of Basic Medical Sciences, Harbin Medical University, Harbin, Heilongjiang, 150081, China.
Zhenhai WangDepartment of Neurobiology, School of Basic Medical Sciences, Harbin Medical University, Harbin, Heilongjiang, 150081, China.
Zhixin QiaoDepartment of Neurobiology, School of Basic Medical Sciences, Harbin Medical University, Harbin, Heilongjiang, 150081, China.
Xinyi WangDepartment of Neurobiology, School of Basic Medical Sciences, Harbin Medical University, Harbin, Heilongjiang, 150081, China.
Yuting WengDepartment of Neurobiology, School of Basic Medical Sciences, Harbin Medical University, Harbin, Heilongjiang, 150081, China.
Xiuhua YaoTianjin Key Laboratory of Cerebral Vascular and Neurodegenerative Diseases, Tianjin Neurosurgical Institute, Tianjin Huanhu Hospital, Tianjin, 300052, China.
Yihe ZhangDepartment of Neurobiology, School of Basic Medical Sciences, Harbin Medical University, Harbin, Heilongjiang, 150081, China.
Xiaoyu ZhangDepartment of Neurobiology, School of Basic Medical Sciences, Harbin Medical University, Harbin, Heilongjiang, 150081, China.
Shanshan SunDepartment of Neurobiology, School of Basic Medical Sciences, Harbin Medical University, Harbin, Heilongjiang, 150081, China.
Zihan XuDepartment of Neurobiology, School of Basic Medical Sciences, Harbin Medical University, Harbin, Heilongjiang, 150081, China.
Wei ZhaoDepartment of Neurobiology, School of Basic Medical Sciences, Harbin Medical University, Harbin, Heilongjiang, 150081, China. zhaowei7700@126.com.
Jianjian WangDepartment of Neurology, The Second Affiliated Hospital of Harbin Medical University, Harbin Medical University, Harbin, Heilongjiang, 150081, China. wangjian_427@163.com.
Lili MuDepartment of Neurobiology, School of Basic Medical Sciences, Harbin Medical University, Harbin, Heilongjiang, 150081, China. mulili@ems.hrbmu.edu.cn.
Jinghua WangDepartment of Neurology, The Second Affiliated Hospital of Harbin Medical University, Harbin Medical University, Harbin, Heilongjiang, 150081, China. wangjinghua@hrbmu.edu.cn.

Funding

Basic Medical Innovation Research Project of Harbin Medical University YJSCX2023-12HYDBasic Medical Innovation Research Project of Harbin Medical University YJSCX2025-78HYDBasic Medical Innovation Research Project of Harbin Medical University YJSCX2025-81HYDBeijing TCM Science and Technology Development Fund BJZY-2025-02-TJHeilongjiang Chunyan Youth Science and Technology Talent Team Project CYQN24009Natural Science Foundation of Heilongjiang Province LH2023H007the Key Project of Heilongjiang Province Outstanding Young Teachers Basic Research YQJH2024129the Open Project Program of State Key Laboratory of Frigid Zone Cardiovascular Diseases HDHY2025012
6 · The paper itself

Abstract

Efficient skeletal muscle regeneration requires precise orchestration of immune cells. The timely recruitment of macrophages is particularly critical, linking inflammation resolution with repair initiation. However, the intrinsic molecular switches governing this process remain elusive. Here, we identify the Immunity-related GTPase family M1 protein (IRGM1) as a central regulator of macrophage-mediated muscle repair. IRGM1 is dynamically upregulated post-injury, with expression kinetics paralleling macrophage infiltration. Using myeloid-specific knockout mice, we demonstrate that macrophage-derived IRGM1 is essential for skeletal muscle regeneration. Its absence results in persistent inflammation, delayed regeneration, and impaired functional recovery. Mechanistically, IRGM1 cell-autonomously governs the intrinsic chemotactic capacity of macrophages. IRGM1 deficiency disrupts the response to damage signals by impairing the inducible expression of key chemokine receptors, including CCR1, CCR2, and CCR5. We further show that IRGM1 functions by negatively regulating the transcription factor Interferon regulatory factor 7 (IRF7). IRF7 abnormally accumulates in IRGM1-deficient macrophages, suppressing their migratory capacity. Notably, IRF7 knockdown rescues this migratory defect. Our results define a novel IRGM1-IRF7 signaling axis that controls the spatiotemporal dynamics of macrophages during muscle repair. By relieving IRF7-mediated suppression of migration, this axis ensures coordinated skeletal muscle regeneration. Our findings thus provide both a new mechanistic rationale and a potential therapeutic target for regenerative disorders.

Indexed as

ChemotaxisGTP-Binding ProteinsInterferon Regulatory Factor-7MacrophagesMuscle, SkeletalRegenerationAnimalsMiceMice, KnockoutSignal TransductionGTP-Binding ProteinsIfi1 protein, mouseInterferon Regulatory Factor-7Irf7 protein, mouseChemotaxisIRF7IRGM1MacrophageSkeletal muscle regeneration

Identifiers

PMID41862677
PMCPMC13043560

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.